Aeromonas: the multifaceted middleman in the One Health world.

Aeromonas / genetics Animals Anti-Bacterial Agents / pharmacology Aquaculture One Health

Journal

Current opinion in microbiology
ISSN: 1879-0364
Titre abrégé: Curr Opin Microbiol
Pays: England
ID NLM: 9815056

Informations de publication

Date de publication:
02 2022
Historique:
received: 31 05 2021
revised: 16 09 2021
accepted: 23 09 2021
pubmed: 31 10 2021
medline: 26 4 2022
entrez: 30 10 2021
Statut: ppublish

Résumé

Aeromonas is at the interface of all the One Health components and represents an amazingly sound test case in the One Health approach, from economic loss in aquaculture tochallenges related to antibiotic-resistant bacteria selected from the environment. In human health, infections following leech therapy is an outstanding example of such One Health challenges. Aeromonads are not only ubiquitous environmental bacteria, able to rapidly colonize and cause opportunistic infections in humans and animals, they are also capable of promoting interactions and gene exchanges between the One Health components. This makes this genus a key amplifier of genetic transfer, especially of antibiotic resistance genes.

Identifiants

DOI: 10.1016/j.mib.2021.09.012 PMID: 34717260
pubmed: 34717260
pii: S1369-5274(21)00131-4
doi: 10.1016/j.mib.2021.09.012
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-32

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Brigitte Lamy (B)

Université de Nice Côte d'Azur, INSERM, C3M, Nice, France; Laboratoire de Bactériologie, CHU de Nice, Nice, France; Centre for Molecular Bacteriology and Infection, Imperial College of London, London, United Kingdom.

Sandrine Baron (S)

Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail, Laboratoire de Ploufragan-Plouzané-Niort, Unité Mycoplasmologie-Bactériologie et Antibiorésistance, Ploufragan, France.

Olivier Barraud (O)

Université de Limoges, INSERM, CHU Limoges, RESINFIT, U1092, Limoges, France. Electronic address: olivier.barraud@unilim.fr.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH

questionsmedicales.fr › Bactéries › Bactéries à Gram négatif › Bâtonnets à Gram négatif facultativement anaérobies › Aeromonas › Aeromonas: the multifaceted middleman in the...
questionsmedicales.fr › Eucaryotes › Animaux › Aeromonas: the multifaceted middleman in the...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Aeromonas: the multifaceted middleman in the...
questionsmedicales.fr › Technologie, industrie et agriculture › Agriculture › Aquaculture › Aeromonas: the multifaceted middleman in the...
questionsmedicales.fr › Caractéristiques de la population › Santé › Une seule santé › Aeromonas: the multifaceted middleman in the...